DSpace Repository

Current and Future Concepts in Treatment of Childhood Atopic Dermatitis Review

Show simple item record

dc.creator Elif Karakoç Aydıner
dc.creator Safa Barış
dc.creator Cevdet Özdemir
dc.date 2011
dc.date.accessioned 2013-05-30T14:02:27Z
dc.date.available 2013-05-30T14:02:27Z
dc.date.issued 2013-05-30
dc.identifier http://www.guncelpediatri.com/eng/makale/3152/98/Full-Text
dc.identifier http://www.doaj.org/doaj?func=openurl&genre=article&issn=13049054&date=2011&volume=9&issue=1&spage=39
dc.identifier.uri http://koha.mediu.edu.my:8181/jspui/handle/123456789/6010
dc.description Atopic dermatitis (AD) is a chronic inflammatory skin disorder caused by a dysregulation of immune response to allergenic or non-allergenic stimuli. Interplay of several effector cells including migrating lymphocytes, fibrocytes, Langerhans cells, mast cells and epidermal keratinocytes enroll in the development of AD. Atopic dermatitis affects approximately 20% of children and persists in 6% of adults. Relieving acute exacerbations, improving the quality of life and prevention of side effects in the long term are the main steps of the management of AD. Mild to moderate cases can be controlled with avoidance of triggering factors, skin care and topical medications. In severe cases immune suppression is an option with cumulative toxicity and variable efficacy of drugs as a limiting factor. It is essential to develop safer and efficacious alternatives for the treatment of AD, especially in pediatric age group. (Journal of Current Pediatrics 2011; 9: 39-43)
dc.publisher Galenos Yayincilik
dc.source Güncel Pediatri
dc.subject Atopic dermatitis
dc.subject allergen
dc.subject child
dc.subject therapy
dc.title Current and Future Concepts in Treatment of Childhood Atopic Dermatitis Review


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account